Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sulfapyridine and sulfones decrease glycosaminoglycans viscosity in dermatitis herpetiformis, ulcerative colitis, and

O J Stone

    Medical Hypotheses
    |February 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thiabendazole inhibition of venom necrosis.

    The Journal of investigative dermatology·2015
    Same author

    Dermatomyositis/polymyositis associated with internal malignancy: a consequence of how neoplasms alter generalized extracellular matrix in the host.

    Medical hypotheses·1993
    Same author

    Pellagra--increased viscosity of extracellular matrix.

    Medical hypotheses·1993
    Same author

    The sign of Leser-Trélat: a cutaneous sign of internal malignancy: weakened subepithelial matrix from the effect of neoplasms on the extracellular matrix of the host.

    Medical hypotheses·1993
    Same author

    Acanthosis nigricans--decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin.

    Medical hypotheses·1993
    Same author

    Inducing viral immunity without a vaccine--possible use with human immunodeficiency virus.

    Medical hypotheses·1993
    Same journal

    Calcitonin Gene-Related Peptide-Induced Central Sensitization: A Hypothesis for Long COVID Symptoms.

    Medical hypotheses·2026
    Same journal

    Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?

    Medical hypotheses·2025
    Same journal

    The Role of Hemispheric Sensory Shifts: Impacts on Stretch Reflex and Motor Plasticity Post-Stroke.

    Medical hypotheses·2025
    Same journal

    Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition.

    Medical hypotheses·2025
    Same journal

    How the Somatosensory System Adapts to the Motor Change in Stroke: A Hemispheric Shift?

    Medical hypotheses·2024
    Same journal

    Unstable Plaque is a Treatable Cause of Cognitive Decline.

    Medical hypotheses·2024
    See all related articles

    Sulfapyridine and sulfones treat specific inflammatory skin and bowel disorders by reducing tissue viscosity, not through antibacterial action. These drugs effectively manage conditions involving edema and inflammation, like dermatitis herpetiformis and ulcerative colitis.

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Sulfapyridine and sulfone drugs exhibit therapeutic properties beyond antibacterial activity.
    • These drugs were found effective in various dermatological conditions, including dermatitis herpetiformis, pyoderma gangrenosum, and subcorneal pustular dermatosis, as well as ulcerative colitis.

    Purpose of the Study:

    • To explore the non-antibacterial therapeutic properties of sulfapyridine and sulfones.
    • To understand the mechanism of action for these drugs in treating specific inflammatory disorders.

    Main Methods:

    • Review of existing experimental data and clinical observations.
    • Analysis of drug effects on conditions characterized by edema and inflammation.

    Main Results:

    • Sulfones are effective in low doses for leprosy and other disorders.

    Related Experiment Videos

  • The drugs are beneficial in conditions with edema followed by granulocytic inflammation or vesicle/bullae formation.
  • Conclusions:

    • The proposed mechanism involves drug interaction with glycosaminoglycans, reducing tissue viscosity.
    • This reduction in viscosity prevents edema and inflammation, explaining therapeutic efficacy in select disorders.